Kronik mukokutanöz kandidiyazis: nadir bir hastalık

Kaynakça (6)

1. Shamriz O, Tal Y, Talmon A, Nahum A. Chronic mucocutaneous candidiasis in early life: Insights into immune mechanisms and novel targeted therapies. Front Immunol 2020;11:593289. Green L, Dolen WK. Chronic candidiasis in children. Curr Allergy Asthma Rep 2017;17:31. Veverka KK, Feldman SR. Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism? J Dermatolog Treat 2018;29:475-80.
2. Khosravi AR, Mansouri P, Saffarian Z, Vahedi G, Nikaein D. Chronic mucocutaneous candidiasis, a case study and literature review. J Mycol Med 2018;28:206-10.
3. Ostadi V, Sherkat R, Migaud M, et al. Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis. Med Mycol 2021;59:180-8.
4. Wang X, Netea MG, van de Veerdonk FL. Genetics of chronic mucocutaneous candidiasis. Immunogenetics of fungal diseases. Springer, 2017, p.85-103.
5. Lehman H, Gordon C. The skin as a window into primary immune deficiency diseases: Atopic dermatitis and chronic mucocutaneous candidiasis. J Allergy Clin Immunol Pract 2019;7:788-98. Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J 2001;20:197-206. van de Veerdonk FL, Netea MG. Treatment options for chronic mucocutaneous candidiasis. J Infect 2016;72:56-60.
6. Egri N, Esteve-Sole A, Deya-Martinez A, et al. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches. Allergol Immunopathol 2021;49: 118-27.